Speaker Profile
M.D., Ph.D., Professor of Medicine (Oncology); C.M.A, Stanford / Foresight
Biography
Ash completed his PhD in Biophysics & MD at Stanford in 2003 under Pat Brown’s mentorship. Supported by HHMI & NIH MSTP, he built and applied the lymphochip microarray platform to profile gene expression in DLBCL and other tumors. This work led to discovery of DLBCL subtypes and a framework for cell-of-origin. Following his clinical subspecialty Hematology & Oncology training, he completed his postdoctoral studies with Ron Levy & Irv Weissman. His lab studies genomic biomarkers of tumors, whether detected through primary tissue biopsies or non-invasively using liquid biopsies. His group has developed several methods for ctDNA detection including CAPP-Seq, PhasED-Seq, and EPIC-Seq, and developed digital cytometry methods (CIBERSORT/x), applying it broadly to human cancers (PRECOG; EcoTyper). His group applies such genomic tools for early detection, diagnosis, and monitoring of diverse tumors. His group builds and employ tools from functional genomics, computational biology, molecular genetics, and disease models.
Session Abstract – PMWC 2023 Silicon Valley
Track Chair: Cindy Perettie, Roche
- PMWC 2023 Award Ceremony
- Luis Alberto Diaz Jr., MSK
- Razelle Kurzrock, Medical College of Wisconsin - Non-invasive Liquid Biopsy Techniques (PANEL)
Chair: Razelle Kurzrock, Medical College of Wisconsin
- Apostolia Tsimberidou, MD Anderson
- Mandana Kamgar, MD Medical College of Wisconsin
- Mina Nikanjam, UCSD
- Ash Alizadeh, Stanford University - Liquid Biopsy Challenges and Limitations (PANEL)
Chair: Victor Lin, Mary Bird Perkins
- Luis Alberto Diaz Jr., MSK
- Maximilian Diehn, Stanford
- Dana Dilbeck, Agilent
- Emma Shtivelman, Cancer Commons - Liquid Biopsy in Clinical Trials: Learnings and COVID Experience (PANEL)
Chair: Cindy Perettie, Roche Diagnostics
- Eric Peters, Genenetch
- Andrew Mckenzie, Sarah Cannon
- Yang Pan, Gilead
- Alan Sandler, Mirati Therapeutics - Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing
Chair: Tom Beer, Exact Sceinces
- Liquid Biopsy for Early Cancer Detection (PANEL)
Chair: Priti Hegde, Foundation Medicine
- Daniel Kim, UCSC
- Mike Nolan, Freenome
- Jeffrey Venstrom, Grail Bio
- Kathryn Phillips, UCSF
- Lon Castle, eviCore healthcare
- Tom Beer, Exact Sciences - Liquid Biopsy for Minimal Residual Disease (PANEL)
Chair: Minetta Liu, Natera
- Peter Bach, Delfi diagnostics
- Laura Vantveer, UCSF
- Susan Bobulsky, Adaptive
- Joshua Cohen, Johns Hopkins
- PMWC Showcase
- Harmeet Dhani, Biological Dynamics
- Varsha Rao, Claret Bio - PMWC NCI Showcase
- Xianghong Jasmine Zhou, EarlyDiagnostics
